Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology
JCI - Applying the discovery of the Philadelphia chromosome
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
Response and Resistance to BCR-ABL1-Targeted Therapies
Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeutics: Cancer Cell
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text